Hudson Bay Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$120M Buy
100,000
+70,000
+233% +$71.5M 0.33% 71
2026
Q1
$27.6M Sell
30,000
-10,000
-25% -$10.1M 0.1% 162
2025
Q4
$43M Sell
40,000
-80,000
-67% -$76.5M 0.14% 132
2025
Q3
$91.6M Sell
120,000
-104,900
-47% -$78.1M 0.3% 63
2025
Q2
$175M Buy
224,900
+21,800
+11% +$16.9M 0.6% 33
2025
Q1
$168M Sell
203,100
-116,900
-37% -$97.3M 0.52% 38
2024
Q4
$247M Buy
320,000
+240,000
+300% +$199M 0.87% 20
2024
Q3
$70.9M Sell
80,000
-310,000
-79% -$279M 0.29% 63
2024
Q2
$353M Buy
390,000
+370,000
+1,850% +$296M 1.66% 11
2024
Q1
$15.6M Buy
+20,000
New +$14.2M 0.09% 125
2018
Q4
Sell
-50,000
Closed -$5.37M 855
2018
Q3
$5.37M Buy
+50,000
New +$5M 0.07% 265

Other funds holding LLY

Hudson Bay Capital Management's LLY Position: Q2 2026 in Review

Hudson Bay Capital Management increased its Eli Lilly (LLY) stake by 49% in Q2 2026, buying an estimated $33.7M and bringing the position to 100,000 shares worth $120M. The position accounts for 0.33% of the portfolio, ranked #70.

Hudson Bay Capital Management first reported a position in LLY in Q1 2021 and has held it in 14 quarters since. The position peaked at $353M in Q2 2024. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hudson Bay Capital Management held 100,000 shares of Eli Lilly worth $120M as of Q2 2026.
  • Hudson Bay Capital Management bought 32,996 Eli Lilly shares in Q2 2026, an estimated $33.7M.
  • Eli Lilly made up 0.33% of Hudson Bay Capital Management's portfolio in Q2 2026, its #70 holding.
  • Hudson Bay Capital Management first reported a position in Eli Lilly in Q1 2021 and has held it in 14 quarters since.
  • Hudson Bay Capital Management's Eli Lilly position peaked at $353M in Q2 2024.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.